MRI contrast using solid-state, B 1-distorting, microelectromechanical systems (MEMS) microresonant devices (MRDs)

Razvan Ciocan, Robert E. Lenkinski, Jonathan Bernstein, Mirela Bancu, Robert Marquis, Alex Ivanishev, Fotini Kourtelidis, Aya Matsui, Jeffrey Borenstein, John V. Frangioni

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Presently, signal generation in MRI depends on the concentration and relaxivity of protons or other MR-active nuclei, and contrast depends on local differences in signal. In this proofof-principle study, we explore the use of nonchemical, solidstate devices for generating detectable signal and/or contrast in vitro and in vivo. We introduce the concept of microresonant devices (MRDs), which are micron-sized resonators fabricated using microelectromechanical systems (MEMS) technology. Fifteen-micrometer (15-μm)-thick, coil MRDs were designed to resonate at the 3T Larmor frequency of protons (127.7 MHz) and were fabricated using tantalum (Ta) oxide thin-film capacitors and copper-plated spiral inductors. The performance of MRDs having final diameters of 300, 500, and 1000 μm were characterized in saline using a radio frequency (RF) scanning microscope and a clinical 3T MR scanner. The measured B 1, fields of 300 μm to 1000 μm MRDs ranged from 3.25 μT to 3.98 μT, and their quality factors (Q) ranged from 3.9 to 7.2. When implanted subcutaneously in the flank of a mouse, only MRDs tuned to the resonant frequency of protons generated a measurable in vivo B 1 field. This study lays the foundation for a new class of solid-state contrast agents for MRI.

Original languageEnglish (US)
Pages (from-to)860-866
Number of pages7
JournalMagnetic Resonance in Medicine
Volume61
Issue number4
DOIs
StatePublished - Apr 2009

Fingerprint

Equipment and Supplies
Protons
Radio
Contrast Media
Copper
Technology

Keywords

  • B field distortion
  • In vivo imaging
  • Magnetic resonance imaging
  • Microelectromechanical systems
  • Solid-state contrast

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Ciocan, R., Lenkinski, R. E., Bernstein, J., Bancu, M., Marquis, R., Ivanishev, A., ... Frangioni, J. V. (2009). MRI contrast using solid-state, B 1-distorting, microelectromechanical systems (MEMS) microresonant devices (MRDs). Magnetic Resonance in Medicine, 61(4), 860-866. https://doi.org/10.1002/mrm.21906

MRI contrast using solid-state, B 1-distorting, microelectromechanical systems (MEMS) microresonant devices (MRDs). / Ciocan, Razvan; Lenkinski, Robert E.; Bernstein, Jonathan; Bancu, Mirela; Marquis, Robert; Ivanishev, Alex; Kourtelidis, Fotini; Matsui, Aya; Borenstein, Jeffrey; Frangioni, John V.

In: Magnetic Resonance in Medicine, Vol. 61, No. 4, 04.2009, p. 860-866.

Research output: Contribution to journalArticle

Ciocan, R, Lenkinski, RE, Bernstein, J, Bancu, M, Marquis, R, Ivanishev, A, Kourtelidis, F, Matsui, A, Borenstein, J & Frangioni, JV 2009, 'MRI contrast using solid-state, B 1-distorting, microelectromechanical systems (MEMS) microresonant devices (MRDs)', Magnetic Resonance in Medicine, vol. 61, no. 4, pp. 860-866. https://doi.org/10.1002/mrm.21906
Ciocan, Razvan ; Lenkinski, Robert E. ; Bernstein, Jonathan ; Bancu, Mirela ; Marquis, Robert ; Ivanishev, Alex ; Kourtelidis, Fotini ; Matsui, Aya ; Borenstein, Jeffrey ; Frangioni, John V. / MRI contrast using solid-state, B 1-distorting, microelectromechanical systems (MEMS) microresonant devices (MRDs). In: Magnetic Resonance in Medicine. 2009 ; Vol. 61, No. 4. pp. 860-866.
@article{d4b9c3cee81742ee813cf7f22067f9eb,
title = "MRI contrast using solid-state, B 1-distorting, microelectromechanical systems (MEMS) microresonant devices (MRDs)",
abstract = "Presently, signal generation in MRI depends on the concentration and relaxivity of protons or other MR-active nuclei, and contrast depends on local differences in signal. In this proofof-principle study, we explore the use of nonchemical, solidstate devices for generating detectable signal and/or contrast in vitro and in vivo. We introduce the concept of microresonant devices (MRDs), which are micron-sized resonators fabricated using microelectromechanical systems (MEMS) technology. Fifteen-micrometer (15-μm)-thick, coil MRDs were designed to resonate at the 3T Larmor frequency of protons (127.7 MHz) and were fabricated using tantalum (Ta) oxide thin-film capacitors and copper-plated spiral inductors. The performance of MRDs having final diameters of 300, 500, and 1000 μm were characterized in saline using a radio frequency (RF) scanning microscope and a clinical 3T MR scanner. The measured B 1, fields of 300 μm to 1000 μm MRDs ranged from 3.25 μT to 3.98 μT, and their quality factors (Q) ranged from 3.9 to 7.2. When implanted subcutaneously in the flank of a mouse, only MRDs tuned to the resonant frequency of protons generated a measurable in vivo B 1 field. This study lays the foundation for a new class of solid-state contrast agents for MRI.",
keywords = "B field distortion, In vivo imaging, Magnetic resonance imaging, Microelectromechanical systems, Solid-state contrast",
author = "Razvan Ciocan and Lenkinski, {Robert E.} and Jonathan Bernstein and Mirela Bancu and Robert Marquis and Alex Ivanishev and Fotini Kourtelidis and Aya Matsui and Jeffrey Borenstein and Frangioni, {John V.}",
year = "2009",
month = "4",
doi = "10.1002/mrm.21906",
language = "English (US)",
volume = "61",
pages = "860--866",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - MRI contrast using solid-state, B 1-distorting, microelectromechanical systems (MEMS) microresonant devices (MRDs)

AU - Ciocan, Razvan

AU - Lenkinski, Robert E.

AU - Bernstein, Jonathan

AU - Bancu, Mirela

AU - Marquis, Robert

AU - Ivanishev, Alex

AU - Kourtelidis, Fotini

AU - Matsui, Aya

AU - Borenstein, Jeffrey

AU - Frangioni, John V.

PY - 2009/4

Y1 - 2009/4

N2 - Presently, signal generation in MRI depends on the concentration and relaxivity of protons or other MR-active nuclei, and contrast depends on local differences in signal. In this proofof-principle study, we explore the use of nonchemical, solidstate devices for generating detectable signal and/or contrast in vitro and in vivo. We introduce the concept of microresonant devices (MRDs), which are micron-sized resonators fabricated using microelectromechanical systems (MEMS) technology. Fifteen-micrometer (15-μm)-thick, coil MRDs were designed to resonate at the 3T Larmor frequency of protons (127.7 MHz) and were fabricated using tantalum (Ta) oxide thin-film capacitors and copper-plated spiral inductors. The performance of MRDs having final diameters of 300, 500, and 1000 μm were characterized in saline using a radio frequency (RF) scanning microscope and a clinical 3T MR scanner. The measured B 1, fields of 300 μm to 1000 μm MRDs ranged from 3.25 μT to 3.98 μT, and their quality factors (Q) ranged from 3.9 to 7.2. When implanted subcutaneously in the flank of a mouse, only MRDs tuned to the resonant frequency of protons generated a measurable in vivo B 1 field. This study lays the foundation for a new class of solid-state contrast agents for MRI.

AB - Presently, signal generation in MRI depends on the concentration and relaxivity of protons or other MR-active nuclei, and contrast depends on local differences in signal. In this proofof-principle study, we explore the use of nonchemical, solidstate devices for generating detectable signal and/or contrast in vitro and in vivo. We introduce the concept of microresonant devices (MRDs), which are micron-sized resonators fabricated using microelectromechanical systems (MEMS) technology. Fifteen-micrometer (15-μm)-thick, coil MRDs were designed to resonate at the 3T Larmor frequency of protons (127.7 MHz) and were fabricated using tantalum (Ta) oxide thin-film capacitors and copper-plated spiral inductors. The performance of MRDs having final diameters of 300, 500, and 1000 μm were characterized in saline using a radio frequency (RF) scanning microscope and a clinical 3T MR scanner. The measured B 1, fields of 300 μm to 1000 μm MRDs ranged from 3.25 μT to 3.98 μT, and their quality factors (Q) ranged from 3.9 to 7.2. When implanted subcutaneously in the flank of a mouse, only MRDs tuned to the resonant frequency of protons generated a measurable in vivo B 1 field. This study lays the foundation for a new class of solid-state contrast agents for MRI.

KW - B field distortion

KW - In vivo imaging

KW - Magnetic resonance imaging

KW - Microelectromechanical systems

KW - Solid-state contrast

UR - http://www.scopus.com/inward/record.url?scp=66249111098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66249111098&partnerID=8YFLogxK

U2 - 10.1002/mrm.21906

DO - 10.1002/mrm.21906

M3 - Article

C2 - 19189289

AN - SCOPUS:66249111098

VL - 61

SP - 860

EP - 866

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

IS - 4

ER -